FDA Approves First Monoclonal Antibody Drug for Pain Control in Cats

The FDA approved the first monoclonal antibody new animal drug approved by the FDA for use in any animal species.

JANUARY 18, 2022

JAK Inhibitors, IL-6 Blockers for COVID-19: Where Do They Fit?

Another JAK inhibitor appears effective in reducing death and respiratory failure in patients hospitalized with ...

JULY 7, 2021

FDA Panel Recommends Against OA Drug Approval

The 15-year journey to bring the osteoarthritis drug tanezumab to clinical use suffered a setback after an FDA ...

MARCH 29, 2021

Tanezumab Shown to Reduce Low Back Pain In Comparison Study

Tanezumab, an investigational monoclonal antibody that inhibits nerve growth factor, was similar to tramadol in ...

NOVEMBER 18, 2020

NGF Inhibitor Reduces Joint Pain but Raises Risk for Deterioration

Tanezumab, an investigational monoclonal antibody that inhibits nerve growth factor, improved joint pain and ...

OCTOBER 15, 2019

FDA Approves New Preventive Injection for Migraine

The FDA approved the first preventive injection for migraine, erenumab-aooe, a once-monthly self-injection, ...

MAY 18, 2018

New Monoclonal Antibody Targets Pathway to Prevent Migraine

The investigational monoclonal antibody galcanezumab has demonstrated efficacy in preventing both episodic and ...

FEBRUARY 15, 2018